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ABSTRACT Oxidative stress adversely affects neuronal cells in which they may die when oxygen supply is reduced or eliminated
and opioid receptor agonists elicit several central nervous system effects. The aim of this study was to evaluate the effect of
oxidative stress on opioid receptor gene expression in cortical B50 cells. The cells were cultured in normoxia, hypoxia and
treated with opioid agonists; DAMGO (µ), DSLET (δ) and ICI—199,441 (κ) for 48 hours after 48 hours of initial culture at
dose of 10µM, 50µM and 100µM. The level of mu opioid receptor mRNA was assessed using RT-PCR. The results show that
oxidative stress induced changes in B50 cells in hypoxia while mu opioid mRNA levels showed no change. The results show
that B50 cells are susceptible to damage by oxidative stress and opioid agonist treatments showed no change in the level of mu
opioid receptor gene expression in B50 cells.
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INTRODUCTION
Oxygen deprivation can lead to oxidative
stress which has been implicated in nerve cell
death that occurs in a variety of neurodegenerative
disorders like dementias, multiple sclerosis,
Alzheimer’s disease and Parkinson’s disease
(Benzi et al. 1994; Maher 2001; Prentice et al.
2011). Oxidative stress leads to metabolic cellu-
lar processes in which oxidative species such as
super oxide radical anions, hydrogen peroxide
and lipid peroxides are generated intracellularly
(Scandalios 1997; Chen and Buck 2000; Lee et
al. 2012). These reactive species, if not elimi-
nated, may damage DNA, proteins or membrane
lipids and cause oxidative cell death. Endog-
enous antioxidative enzymes as well as antioxi-
dants are required for cells to survive (Semenza
2005), while exogenous antioxidants have been
shown to effectively prevent oxidative cell death
in cultured cells (Busciglio and Yankner 1995;
Nakao et al. 1996; Du et al. 2012).
Hypoxic stress results in a rapid and sus-
tained inhibition of protein synthesis that is
partially mediated by eukaryotic initiation fac-
tor 2alpha (eIF2alpha) phosphorylation by the
phospho-endoplasmic reticulum kinase (PERK)
(Blais et al. 2004). Severe hypoxia has been
shown to induce apoptotic cell death in develop-
ing brain neurons whereas mild hypoxia has
been demonstrated to stimulate neurogenesis
(Bossenmeyer-Pourie et al. 2002; Yeh et al.
2008). Hypoxia threatens brain function through-
out the entire life span and although the physi-
ological consequences of brain hypoxia are well
documented, the molecular mechanisms involved
in these processes are still not well understood
(Rossler et al. 2001; Zhu et al. 2005; Semenza
2006, Semenza 2007). It has been shown that
hypoxia may have severe detrimental effects on
most cells and especially on neuronal cells. The
responses of cells to hypoxia may involve the
induction of specific gene expression which may
help to suppress the effects of hypoxia in cells
(Yun et al. 1997; Kim et al. 2012; Lee et al.
2012).
Gibson and Huang (2002) used the oxidative
processes in the brain as a biomarker of Alzhei-
mer’s disease and showed that diminished me-
tabolism and excessive oxidative stress occur in
brains of patients with Alzheimer’s disease. It
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has been observed that oxidative stress can cause
neurodegeneration associated with enhanced
susceptibility to apoptosis due to the activation
of pro-apoptotic genes (Gibson and Huang 2002;
Du et al. 2012). Hypoxia-induced oxidative stress
can cause neurite retraction leading to neuro-
degeneration and neuronal loss similar to that
found in Alzheimer’s disease (Banasiak et al.
2000; de la Monte et al. 2000; Yeh et al. 2008;
Prentice et al. 2011; López-Hernández et al.
2012).
Opioid receptors, found in the central
nervous system are classified as mu (µ), kappa
(κ), delta (δ) and sigma (σ) opioid receptors.
These receptors are not uniformly distributed
in the CNS with the highest concentration in
the cerebral cortex (Raynor et al. 1996; Chatur-
vedi et al. 2000). The mu receptor has been
shown to be high in areas of pain perception
and in the medulla, especially in the area for
respiration (Hasbi et al. 2000; Fichna et al.
2006; Li et al. 2012).
The opioid receptors (mu, delta, and kappa)
belong to the large family of GPCRs and have
diverse and important physiological roles (Pies-
trzeniewicz et al. 2006). Laugwitz et al (1993)
have shown that activated delta opioid receptors
are coupled to G
i1
 while activated mu opioid
receptors are coupled to G
i3 
in neuroblastoma
cells. Mu opioid receptors have been shown to
be activated by mu receptor agonists and are
coupled through the Gα
i1
 and Gα
oA
 in human
embryonic kidney cells (Saidak et al. 2006). Tso
and Wong (2000) have shown that both mu and
kappa opioid receptors are coupled via both G
i
and G
z
 in HEK 239 cells. The stimulation of
opioid receptors triggers analgesic effects and
affects the function of the nervous system,
gastrointestinal tract and other body systems
(Piestrzeniewicz et al. 2006; Wang et al. 2007;
Vermehren-Schmaedick et al. 2012).
Objective of the Study
The aim and the objectives of the present
work was to investigate the expression of opioid
(mu) receptor gene in B50 neuronal cells, to
investigate the effect of oxidative stress using
hypoxia on the expression of mu opioid receptor
gene on B50 cells and to study the effect of mu
opioid receptor agonist treatment on opioid (mu)
receptor gene in cultured B50 cells using semi
quantitative Reverse Transcription Polymerase
Chain Reaction (RT-PCR).
MATERIAL AND METHODS
Neuronal Culture
One group of B50 neuronal cells were cul-
tured and maintained in a normoxic incubator
(21%O
2
; 5% CO
2
) as control group and another
batch of cells cultured under hypoxia (5%O
2
;
5% CO
2
) as experimental group. Cells were
cultured in 12-well culture plates for 48 hours
and were treated with opioid agonists to deter-
mine their effects on hypoxia-induced changes.
Three opioid agonists {DAMGO (µ), DSLET
(δ) and ICI—199,441(κ)}, and antagonists were
administered to the cells as treatment against
hypoxia for 48 hours for a total of 96 hours at a
concentration of 10µM, 50µM and 100µM. The
total cellular Ribonucleic acid (RNA) was
extracted from the cultured B50 neuronal cells
using the TRIzol reagent method (Invitrogen
No 15596-026).
Method
The B50 cells in the different groups were
grown and lysed in culture plates by adding
0.5ml of TRIzol reagent to each well. The cells
were homogenized and incubated for 5mins at
room temperature. The homogenates were trans-
ferred to micro-centrifuge tubes, 0.1ml of chlo-
roform added, the cap secured and the tubes
shaken vigorously by hand for 15 seconds. The
cellular mixture was incubated at room tempera-
ture for 3 minutes. The mixture was then centri-
fuged at 12,000 x g for 15 minutes at room
temperature. Following centrifugation, the mix-
ture, separated into 3-layers namely a lower
phenol-chloroform phase (Red), a middle inter-
phase (Cloudy) and an upper aqueous colourless
phase. The RNA was present at the upper aque-
ous phase and formed about 60% of the total
volume of the mixture and was transferred to a
fresh micro-centrifuge tube. The aqueous phase
was mixed with 0.25ml of isopropyl alcohol and
incubated for 10 minutes at room temperature.
The mixture was then centrifuged at 12,000 x g
for 10 minutes at room temperature. At this
point the RNA precipitated and formed a gel-
like pellet.
The supernatant was removed and the re-
maining RNA pellet was washed once with
0.5ml of 75% ethanol and mixed by vortexing.
The mixture was centrifuged at 7,500 x g for 5
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minutes at room temperature and the ethanol
was decanted. The RNA was then air dried for 10
minutes, dissolved in 100% deionized formamide
and stored at -70oC to be used in RT-PCR ana-
lysis.
Semi-quantitative One step
RT-PCR Analysis
The semi-quantitative one step reverse tran-
scriptase polymerase chain reaction (RT-PCR)
was used to study the gene expression of mu
opioid receptors. Mu opioid receptor (MOR)
was selected for the semi-quantitative RT-PCR
analysis because opioid receptor subtypes have
been shown to have 68% sequence homology
between them and the differences between them
was proposed largely, on the basis of radioligand
binding studies and as such there is little or no
evidence for the presence of the different genes
encoding the opioid receptor subtypes (Corbett
et al. 2006). In some cases receptor hetero-
dimerisation of opioid receptors has been pro-
posed as a possible explanation for the different
opioid receptor subtypes (Milligan 2004).
The extracted total RNA, Superscript III RT/
Platinum Taq Mix, Reaction Mix, 5nM Magne-
sium Sulphate, GeneAMP PCR System thermal
cycler were used according to the manufacturer’s
instruction. Mu opioid receptor (MOR) sense
primers, 5-GGA ACA TGG CCC TTC GGA
ACC ATC-3' (574-597) and antisense 5'-TAC
CAG GTT GGG TGG GAG AAC GTG-3' (863-
840), were selected from Silbert et al. (2003),
where they were used to study the effect of MOR
expression and opioid treatment in myelinated
and unmyelinated neurons. Alpha actin primer
Sense  5’-GAT CAC CAT CGG GAA TGA
ACG C-3’  (389bp) and Antisense 5’-CTT AGA
AGC ATT TGC GGT GGA C-3’, selected from
Park et al. (1997), where they were used as an
internal control for cytoskeletonal study in
pericytes.
Programming of the thermal cycler was done
as follows: cDNA synthesis 1 cycle at 55oC for
30 minutes, Denaturation 1 cycle at 94oC for 2
minutes, PCR amplification 40 cycles at 94oC
for 15 seconds (Denature), 60oC for 30 seconds
(Anneal), 68oC for 60 seconds (Extend), Final
extension, 1 cycle at 68oC for 5 minutes.
The master mix was prepared on ice using
0.2ml nuclease free, thin walled PCR tubes.
Each PCR tube contained the following: 2 x
Reaction mix (dNTPs: 200µM; MgSO
4
:1.6mM)
25µl, Template RNA (200ng/µl) 1µl, Sense
Primer (0.2µM), 1µl, Antisense Primer (0.2µM)
1µl, SuperScript III RT/ Platinum Taq mix
(5mM) 2µl, Autoclaved distilled water; 20µl
was added to make up total volume to 50µl.
These were mixed together gently and all the
components were allowed to settle at the bottom
of the amplification tube. The tubes were then
centrifuged briefly by pulse centrifugation, over-
laid with one drop of mineral oil and placed in
a preheated thermal cycler (GeneAMP PCR
System) as programmed above. One tube was
used as blank and contained only master mix
and water.
Analysis of the RT-PCR Products
The analysis of the PCR products was carried
out using the following method. Agarose gel
(2%) was made by dissolving 2.5g agarose in
112.5ml of distilled water which was sub-
sequently micro-waved in a conical flask for 5
minutes. 12.5ml buffer solution of Tris/Borate/
EDTA (TBE) was added and 5µl of ethidium
bromide added for staining the mRNA and
mixed thoroughly. The mixture was poured into
the gel tray with combs in place and air bubbles
pushed to the sides with a pipette. The gel was
allowed one hour to set. 5µl of Blue loading
buffer (Sigma, G7654), which contain brom-
phenol blue (0.25% w/v), xylene cyanole FF
(0.25% w/v), sucrose (40% w/v), was added to
each of the samples and centrifuged briefly to
mix and settle.
A 10µl deoxyribonucleic acid (DNA) ladder
(Promega G2101) and 5µl Blue loading buffer
was used to make-up the DNA marker, and one
litre of gel buffer was made using the TBE in a
1:10 dilution. The gel was placed in an electro-
phoresis tank with wells at the negative elect-
rode such that RNA will move towards the
positive electrode. The gel was then surrounded
with gel buffer and the wells completely covered
by the buffer. The DNA marker (5µl), was added
to the gel on position one, followed by adding
a 10µl blank sample to the next position, and
continuing to add 10µl of each sample to the
remaining wells. The electrophoresis tank was
connected to a power supply set at 125V for
one hour. Photographs of the gels were taken
and scanned using the digital densitometer to
evaluate and semi-quantify the mRNA of the
OXIDATIVE STRESS INDUCED GENE EXPRESSION IN NEURONAL CELLS 305
receptors, and then compared between the
different groups.
Statistical Analysis
The different parameters measured from the
normal, hypoxic and treated experimental groups
of B50 neuronal cells were compared using
mean and standard deviation (SD). The param-
eters were assayed in triplicate and repeated
twice (n = 6) and the results presented as the
mean ± SD. The Students’t-test was used for
testing the level of significance between two
groups and a P-value less than 0.05 was consid-
ered to be significant using Microsoft Excel®
package. For multiple treatment data, One-Way
Analysis of Variance (ANOVA) was used fol-
lowed by Multiple Range Test post hoc subgroup
testing to find the least significant difference
(LSD) between the groups.
RESULTS
Morphological Studies
Morphological changes were observed in B50
cells cultured under hypoxia when compared to
cells cultured in normoxia. The B50 cells in
hypoxia showed clustered groups of neuronal
B50 cells, evidence of degenerating, dying cells
and already degenerated and dead neuronal B50
cells. The normal B50 neuronal cells cultured
under normal incubator showed normal neu-
ronal morphology (Figs. 1 and 2), when com-
pared to B50 cells in hypoxia (Figs. 3 and 4).
Fig. 1. Representative of B50 cells (arrow) at the point of
starting the culture at 21% O
2
 and 5% CO
2
. B50 cells
were observed in three different plates with same field
method in a quadri-point analysis under the Nikon Eclipse
TS1 microphotographs processed with an IBM Image
Solutions. Scale bar = 5mm x 40 magnification
Fig. 2. Representative of B50 cells at 48 hrs of normal
culture (21% O
2
 and 5% CO
2
) and B50 cells (arrow). B50
cells were observed in three different plates with same field
method in a quadri-point analysis under the Nikon Eclipse
TS100 microscope and microphotographs processed with
IBM Image Solutions. Scale bar = 5mm x 40 magnifi-
cation
Fig. 3. Representative of hypoxic B50 cells at 48 hrs of
culture (5% O
2
 and 5% CO
2
) without drug administra-
tion, showing groups of degenerating cells (arrow). Groups
of degenerating cells were observed in six different plates
with same field method in a quadri-point analysis under
the Nikon Eclipse TS100 microscope and microphoto-
graphs processed with an IBM Image Solutions. Scale
bar = 5mm x 40 magnification
The Effect of Hypoxia on the Expression of
Mu Opioid Receptor Gene in B50 cells
The result of Mu receptor gene expression in
B50 neuronal cells in normal, hypoxic and
treated cells was studied using reverse transcrip-
tion polymerase chain reaction (RT-PCR). The
results showed that the RT-PCR experiments
with the B50 neuronal cells in normal, hypoxic
and treated cultures demonstrated positive gene
expression of the Mu opioid receptors. The
mRNA levels of Mu opioid receptors in hypoxic
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Fig. 4. Representative of B50 cells in hypoxia at 96 hrs of
culture (5% O
2
 and 5% CO
2
) with groups of degenerat-
ing cells (arrow). B50 cells was observed in six different
plates with same field morphological method in a quadri-
point analysis under the Nikon Eclipse TS100 microscope
and microphotographs processed with an IBM Image
Solutions. Scale bar = 5mm x 20 magnification
culture of B50 cells were expressed relative to
Mu opioid receptors in B50 cells cultured under
normal conditions, and these were also com-
pared with mRNA levels of mu opioid receptors
in hypoxic B50 cells treated with different re-
ceptor agonists (Fig. 5). The results showed that
there were no significant difference in the levels
of mu opioid receptor gene and mRNA expres-
sion between the normal, hypoxic and agonist
treated cultured B50 cells.
Semi-quantitative RT-PCR of
Cannabinoid CB
1
 and MOR
MOR expression products were subjected to
semi quantitative analysis using digital densito-
metric measurements. The decrease in the den-
sity of MOR RT-PCR products was not signifi-
cant in untreated (MOR) hypoxic cells (93%)
Fig. 5. The effect of ipioid treatment on MOR expression
in cultured B50 cells in hypoxia A = DNA Ladder, B =
Normal cells; C = Hypoxic cells; DEF = Hypoxic MOR
treated G = Alpha Actin
Table 1: Semi-quantitative RT-PCR product of MOR receptors in B50 cells in culture
Treatment type  Vol.mm3 Areamm2 STD  ± Density Width Height % of % of
Normal Control
MOR receptor was expressed in B50 neuronal cells in culture with total RNA extracted from B50 cells in normal (21%O
2,
5%CO
2
), hypoxic (5%O
2,
 5%CO
2
) and hypoxia treated with MOR
 
agonists. The RT-PCR was amplified with specific MOR
primers and gel was electrophoresed and stained with ethidium bromide and normalised relative to alpha actin. The RT-PCR
product was quantified with digital densitometer and expressed as percent of control. (Data presented as mean ±SD; Student’s
t-test)
4.04
1.94
5.90
5.34
4.29
4.44
3.22
0.32
0.24
0.35
0.34
0.35
0.33
0.32
621.12
583.40
613.07
579.21
613.22
631.09
519.46
2.78
0.76
2.73
1.59
1.78
2.79
2.02
1.56
2.54
2.16
3.37
2.41
1.59
3.12
100
  93.93
  98.70
  93.27
  98.73
101.61
  83.63
11.20
04.55
14.57
12.48
10.61
11.29
10.35
MOR Normal
MORHypoxia
10µM DAMGO
50µM DAMGO
100µM DAMGO
DAMGO/CTAP
Alpha actin
119.57
112.31
118.02
111.50
118.05
121.49
100
and those treated with 10µM DAMGO (98%);
50µM DAMGO and 100µM DAMGO (98%).
There was no significant change in densitomet-
ric measurements of mRNA area, mRNA vol-
ume, height and width respectively when com-
pared with the normal control B50 cells (Table
1).
When the density of the RT-PCR products
was normalised to alpha actin (100%), there was
no observed difference in the level of the recep-
tor mRNA expression of MOR in normal, hy-
poxic and treated cultured B50 cells. The results
showed no significant difference between the
normal MOR (119%); 10µM DAMGO (118%);
50µM DAMGO (111%) and 100µM DAMGO
(118%).
Mu opioid receptor (MOR) expression in
B50 neuronal cells in culture of which the total
RNA was extracted from cultured B50 cells in
normal (21%O2, 5%CO2), hypoxic (5%O2, 5%
CO2) and hypoxia treated with MOR agonists.
RT-PCR amplification was performed with spe-
cific MOR primers. The gel was electrophoresed
and stained with ethidium bromide to visualise
the intensity of the cDNA for MOR (209bp) and
was normalised relative to alpha actin (350bp).
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DISCUSSION
The use of experimental approaches which
include morphological assessments, cell live
and dead trypan staining, viability and prolif-
eration assay was used to assess neuronal injury
more directly from hypoxia. Reactive oxygen
species generated during hypoxia-ischaemia
contribute to the cellular injury. Oxygen free-
radicals serve as important signalling molecules
that trigger cell death and apoptosis in neuronal
cells (Durukan and Tatlisumak 2007; Lee et al.
2012). The findings of Mahura (2003), have
shown that any neuroprotective agent against
hypoxia and ischaemia should be able to reduce
the generation of oxygen free radicals and limit
Ca2+ influx into neuronal cerebral cells, which
will invariably reduce inflammation and cell
death.
This study has demonstrated that stimulation
of opioid receptors proffers some protection by
reducing neuronal cell injuries and deaths after
treatments in hypoxic conditions but the benefit
is reduced substantially with prolonged expo-
sure durations and higher concentrations of the
drugs, results not shown here. This supports the
finding that the longer the neurons stayed in the
culture media in the experimental hypoxic
groups, the greater the extent of the neuronal
cell injuries and death (Francis and Wei 2010;
Du et al. 2012; Prentice et al. 2012). A possible
explanation for this phenomenon is that pro-
longed hypoxia may cause a significant release
and accumulation of endogenous glutamate
which causes glutamate-induced toxicity and
hence death of the cells (Nyakas et al. 1996; Yeh
et al. 2008; Francis and Wei 2010).
It has been shown that in response to short-
term hypoxia, the level of enkephalins, the en-
dogenous agonists for opioid receptors sharply
increases (Zhang et al. 2002; Khasabova et al.
2002; Kirbach and Golenhofen 2011). This
showed that cortical neurons may release opio-
ids during normal function and in response to
hypoxic stress as a mechanism of self-protection
against injury (Ma et al. 2005; Wallace et al.
2006; Lee et al. 2012). Zhang et al. (2002)
showed that because of high levels of endog-
enous opioids which may already be present in
the culture media after prolonged exposure to
hypoxia, adding more agonist may not increase
the protection by the drugs. However, cellular
injury was observed in cultured B50 neurons in
hypoxic conditions which suggest that matura-
tional differences exist between the different age
group of the neurons. This supports the work of
Zhang et al. (2000), which showed that opioid
receptor expression increases significantly with
development in both brain and cultured neu-
rons. This is because the opioid receptor density
increases with increase in the age of the neurons
though the result from this present study shows
that there was no difference in the mu opioid
receptor gene expression and no significant
change in the expression densities of the mu
opioid receptors was observed. The more mature
neurons may have greater dependence on this
pathway to maintain neuronal function and there-
fore may be more susceptible to neuronal injury
with opioid receptor inhibition (Xue et al. 2011;
Lee et al. 2012). This observation suggests that
the increase in opioid receptor agonist may
compete with opioid receptor antagonist in terms
of opioid receptor binding and thus reduce neu-
ronal injury induced by opioid receptor inhibi-
tion during prolonged hypoxia (Wallace et al.
2006; Yu et al. 2009; Xue et al. 2011). This is in
support of the findings in this study in which at
higher concentration of the agonists and antago-
nist treatment against hypoxia could have led to
complete inhibition of the agonists activities in
cultured B50 cells in hypoxia.
Another issue is whether the differences in
the expression levels of the various opioid
receptors accounted for the observed pheno-
menon in cortical neurons. Past studies have
demonstrated that µ-opioid receptors are present
at similar or even higher densities than δ-opioid
receptors in mammalian cortex, although κ-
opioid receptor density is slightly lower (Zhang
et al. 2006). This implies that the relative
distribution and expression levels of opioid
receptor subtypes within the cortex as a whole
may not be a key factor in the observations
shown in this work. This is because the results
presented in this study showed that there were
no observed differences in the receptor express-
ion densities of µ-opioid receptors in normoxic,
hypoxic and hypoxic treated B50 cells.
It has been shown that intracellular Ca2+
levels were elevated during hypoxic exposure
leading to irreversible cell injury while the
inhibition of Ca2+ currents by opioid receptor
stimulation by DAMGO, DSLET and ICI-
199441, may serve as a neuroprotective mech-
anism in preventing Ca2+ overload (Andersen
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2004; Bossy-Wetzel et al. 2004; Shimamura et
al. 2012), and this could be the situation with
the protection proffered by the µ-, δ- and κ-
opioid agonists used in this study. This mech-
anism of cellular regulation may be utilised
during normal cell functioning and in response
to oxidative stress like hypoxia (Andersen 2004;
Shimamura et al. 2012). The δ-, µ- and κ-opioid
receptors have many similarities such as seven
transmembrane domains existing as 60% iden-
tical sequences and being coupled to G
i/o
 pro-
teins. Connor and Christie (1999) had proposed
that because of the common features of opioid
receptors, the selectivity of these receptors for
eliciting specific pathways does not lie in the
differences between each opioid receptor sub-
type but in their association with other divergent
types of G proteins. It was observed that each
opioid receptor subtype also preferentially
couples to specific G proteins apart from the
G
i/o
 proteins that they generally couple (Zhang
et al. 2002; Vermehren-Schmaedick et al.
2012). Examples of this preferential coupling
include as seen in δ-opioid receptors which are
more efficiently coupled to Gα
16
 protein than
either µ- or κ-opioid receptors (Lee et al. 1998,
Lee et al. 2012). Also µ-receptor agonist
(DAMGO) has been reported to have a selective
coupling to Gα
i1
 and Gα
oA
 opioid receptors than
other opioid agonists (Saidak et al. 2006). This
shows that the opioid receptor agonists have
selective activation of G-proteins in response
to opioid receptor activation. This preferential
coupling to other G protein subtypes may be
the reason for the observed differences in the
effect of the opioid agonists on the B50 cells
treated in hypoxia.
CONCLUSION
The results from the present study showed
that hypoxia induced morphological changes in
B50 cells in hypoxia while the Mu RT-PCR
mRNA levels showed no appreciable changes in
normal, hypoxic and cells treated with Mu opioid
receptor agonists. The results show that B50
neuronal cells are susceptible to injurious effects
of oxidative stress agents like hypoxia, as are
most brain cells and the Mu opioid receptor
agonist treatments showed that there were no
changes in the level of Mu
 
opioid
 
receptor gene
expression due to hypoxia or agonist treatment
in cultured cortical neuronal B50 cells.
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